Key result
Disruption of the KCNQ2 gene in mice caused neonatal death in homozygotes and hypersensitivity to pentylenetetrazole in heterozygotes, indicating neural hyperexcitability.
Decreased expression of KCNQ2 causes CNS hyperexcitability, providing a mechanism for benign familial neonatal convulsion (BFNC).
Supports KCNQ2 hyperexcitability as BFNC mechanism in mice; hypothesis-generating for human translation.
Benign familial neonatal convulsion (BFNC) is a common idiopathic epilepsy with autosomal dominant inheritance. Recently, two novel voltage-dependent potassium channel genes, KCNQ2 and KCNQ3, were identified by positional cloning as being responsible for BFNC. Heterotetramers of the products of these genes form M-channels and regulate the threshold of electrical excitability of neurons. We disrupted the mouse KCNQ2 gene via gene targeting to study the relationship between KCNQ2 and epilepsy. Homozygous pups (KCNQ2 -/-) died within a few hours after birth owing to pulmonary atelectasis that was not due to the status of epileptic seizures, although their development was morphologically normal. Heterozygous mice had decreased expression of KCNQ2 and showed hypersensitivity to pentylenetetrazole, an inducer of seizure. These data indicate that the decreased expression of KCNQ2 might cause a hyperexcitability of the CNS, which accounts for the mechanism of BFNC.
No takes yet. Share an insight, caveat, or question.
Nagata et al. (2000) studied Benign familial neonatal convulsion (BFNC). KCNQ2 gene disruption vs. Wild-type (implied) was evaluated on Survival and hypersensitivity to pentylenetetrazole. Disruption of the KCNQ2 gene in mice caused neonatal death in homozygotes and hypersensitivity to pentylenetetrazole in heterozygotes, indicating neural hyperexcitability.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: